Yahoo Web Search

Search results

    • Europe Awaits Decision on New Duchenne Drug

      Medscape· 2 days ago

      The US Food and Drug Administration (FDA) has recently approved Duvyzat (givinostat), the first nonsteroidal therapy for children aged 6 years and older who have all hereditary variants of Duchenne ...